Single daily dose methimazole treatment of hyperthyroidism

Area of Science:

• Endocrinology
• Pharmacology

Background:

• Hyperthyroidism is a common endocrine disorder.
• Antithyroid drugs are a primary treatment for hyperthyroidism.

Purpose of the Study:

• To evaluate the effectiveness of methimazole in a single daily dose for treating hyperthyroidism.
• To compare the time to achieve a euthyroid state with methimazole versus propylthiouracil.

Main Methods:

• A study involving 47 patients with initial hyperthyroidism episodes and 8 with relapsed hyperthyroidism.
• All patients were treated with methimazole in a single daily dose regimen.
• Time to achieve a euthyroid state was recorded.

Main Results:

• All patients achieved a euthyroid state with single daily dose methimazole.
• Mean time to euthyroid state was 16.7 weeks for initial episodes and 14.9 weeks for relapses.
• Propylthiouracil demonstrated a faster euthyroid state achievement than methimazole.

Conclusions:

• Single daily dose methimazole is an effective treatment for most hyperthyroidism cases.
• Propylthiouracil may offer a more rapid therapeutic response compared to methimazole.